WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

BMO Capital analyst Evan Seigerman upgraded Replimune (REPL) to Market Perform from Underperform with a price target of $11, up from $2. The firm ...

Democratic officials in 25 states who sued the Trump administration to keep SNAP benefits flowing temporarily during the ...

The South Kalimantan Provincial Government, through the Plantation and Livestock Agency (Disbunnak), continues to ...

Dozens of cemeteries across Ohio will soon receive financial assistance to help preserve their history and make them safer for visitors. The Ohio Department of Commerce’s Division of Real Estate and ...

Dozens of cemeteries across Ohio will soon receive financial assistance to help preserve their history and make them safer for visitors. The Ohio Department of Commerce’s Division of Real Estate and ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Qure (QURE) shares drop after FDA questions AMT-130 data for Huntington’s disease, delaying BLA submission. Read more here.

SPRINGFIELD, Mo. (KY3) - KY3 programming has returned to YouTube TV, Hulu, Fubo, and Peacock. KY3 worked with NBC throughout the week to fix a technical issue related to the outage. KY3 apologizes for ...

WASHINGTON — The Department of Army today announced the launch of the Janus Program, a next-generation nuclear power program that will deliver resilient, secure, and assured energy to support national ...

Features case studies on successful automation implementations for commercial mining operations at scale in Australia ...